Based in the United States, Alamar Bio is a startup.
Alamar Bio develops a highly sensitive, fully automated multiplex proteomics platform capable of profiling thousands of proteins from minimal blood samples to enable discovery and clinical use of protein biomarkers for disease detection and research.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.